A bonus issue makes a share easier for small investors to buy and trade. Concord Biotech's board has approved a 1:1 bonus — one free share for each held — and doubled its authorised capital to ₹22 crore. A bonus creates no new value on its own; it splits the same company into more, cheaper shares and signals management's confidence and wish for wider retail ownership. The record date is yet to be fixed.
